Which drug commonly used as an immunosuppressant is especially noted for liver transplant patients?

• A. Methotrexate
• B. Amiodarone
• C. Tacrolimus
• D. Paroxetine

Answer: (C)

Tacrolimus is the drug most closely associated with preventing rejection after liver transplantation. It’s a calcineurin inhibitor that works by binding to FKBP12, and this complex blocks calcineurin’s ability to activate T cells. Without calcineurin signaling, the transcription of interleukin-2 and other cytokines is reduced, so T-cell activation and the immune response against the newly transplanted liver are dampened. This mechanism makes tacrolimus a mainstay in liver transplant immunosuppressive regimens, often used in combination with steroids and other agents.

Understanding why the others don’t fit helps: methotrexate is primarily a chemotherapeutic/immunomodulatory drug used for certain cancers and autoimmune diseases, not the standard backbone for liver transplant immunosuppression; amiodarone is an antiarrhythmic; paroxetine is an antidepressant. Tacrolimus’s targeted effect on T-cell activation is what makes it especially suited for preventing transplant rejection.